TDF-prescribing physicians must be prepared to detect signs and symptoms of renal dysfunction and immediately consider switching to another antiviral drug.
Tenofovir-associated Fanconi‘s syndrome and rickets in a HIV infected girl
 
  Keywords
 
 
  
   Renal tubulopathies
  
 
 
  
   Drug-related side effects
  
 
 
  
   Hypophosphatemic rickets
  
 
 
  
   HIV
  
 
Introduction.
Tenofovir (TDF) is an inhibitor of reverse transcriptase nucleotide analogue, although it has good tolerability and high anti-retroviral activity, its effect on the kidney has been a concern.

Objective.
To describe a girl infected with HIV who presented Fanconi syndrome during antiretroviral therapy with TDF.

Clinical case.
We describe a HIV-1-infected girl, who after 18 months treatment with TDF presented loss of strength and pain of the lower extremities with <dis>functional impairment</dis>. 
Laboratory findings were consistent with Fanconi syndrome. 
Radiographs showed bilateral hip fracture and wrists. 
Full recovery of Fanconi syndrome was achieved four months after changing antiretroviral therapy.

Conclusions.
TDF-prescribing physicians must be prepared to detect signs and symptoms of renal dysfunction and immediately consider switching to another antiviral drug.

Introduction.
Tenofovir (TDF) is an inhibitor of reverse transcriptase nucleotide analogue, although it has good tolerability and high anti-retroviral activity, its effect on the kidney has been a concern.

Objective.
To describe a girl infected with HIV who presented Fanconi syndrome during antiretroviral therapy with TDF.

Clinical case.
We describe a HIV-1-infected girl, who after 18 months treatment with TDF presented loss of strength and pain of the lower extremities with functional impairment. 
Laboratory findings were consistent with Fanconi syndrome. 
Radiographs showed bilateral hip fracture and wrists. 
Full recovery of Fanconi syndrome was achieved four months after changing antiretroviral therapy.

Conclusions.
TDF-prescribing physicians must be prepared to detect signs and symptoms of renal dysfunction and immediately consider switching to another antiviral drug.

TDF-prescribing physicians must be prepared to detect signs and symptoms of renal dysfunction and immediately consider switching to another antiviral drug.